Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03413982

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
University of Kansas Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.

Conditions

Interventions

TypeNameDescription
OTHERRegistryPatient registry

Timeline

Start date
2017-11-02
Primary completion
2035-01-01
Completion
2035-01-01
First posted
2018-01-29
Last updated
2026-03-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03413982. Inclusion in this directory is not an endorsement.

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers (NCT03413982) · Clinical Trials Directory